Ampicillin Injection, Powder, For Solution
Product Images NDC 51662-1595

13 FDA label images from Hf Acquisition Co Llc, Dba Healthfirst · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 13 technical images submitted to the FDA as part of the official labeling for Ampicillin (NDC 51662-1595). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hf Acquisition Co Llc, Dba Healthfirst, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Structure)

Structure (Structure)
Chemical structure of AMPICILLIN depicted with key functional groups including a beta-lactam ring, a side chain with a carboxylate sodium salt (COONa), and an amide linkage connecting a phenyl group to the central core.*
FDA Label Image

Dosage1 (D1)

Dosage1 (D1)
A data table showing dosages of Ampicillin injection powder for solution based on gestational age in weeks and postnatal age in days. It correlates dosing schedules in mg/kg/day with specific age ranges, detailing dosage frequency for different age categories.*
FDA Label Image

D2 (Dosage 2)

D2 (Dosage 2)
A data table presenting Ampicillin injection powder for solution with NDC 51662-1595. It details the label claim of 250 mg, recommended diluent amount of 1 mL, withdrawable volume of 1 mL, and concentration of 250 mg/mL.*
FDA Label Image

Dosage3 (D3)

Dosage3 (D3)
A data table showing stability periods of AMPICILLIN injection powder when reconstituted with various diluents at different concentrations. The table specifies stability times at room temperature (25°C) and refrigerated conditions (4°C) for diluents including Sterile Water for Injection, 0.9% Sodium Chloride Injection, 5% Dextrose Injection, 5% Dextrose with 0.45% Sodium Chloride, and Lactated Ringer's Injection.*
FDA Label Image
FDA Label Image

Pouch Labeling (Pouch)

Pouch Labeling (Pouch)
Label for Ampicillin for Injection 250 mg/10 mL vial. Displays NDC 51662-1595-2, lot number, and expiration date. Instructions for use indicate dissolving the vial's contents with sterile water for injection. Manufactured by HF Acquisition Co LLC, DBA HealthFirst, Mukilteo, WA.*
FDA Label Image

Vial Labeling (Vial)

Vial Labeling (Vial)
Label for AMPICILLIN injection, USP powder for solution, showing 250 mg per vial strength. The vial is for intravenous or intramuscular use, packaged by Fresenius Kabi USA, LLC. The label includes preparation instructions, storage conditions, and a barcode with lot and expiration date fields.*
FDA Label Image

Case Labeling (Case)

Case Labeling (Case)
Ampicillin for Injection 250 mg/10 mL vial, shown as a case label. The label includes dosage form as powder for solution for intramuscular or intravenous use. Packaging is a case containing 10 vials. Manufacturer is HF Acquisition Co LLC, DBA HealthFirst. The label displays NDC 51662-1595, lot number, expiration date, and usage instructions.*
FDA Label Image

Rfid Label (51662 1595 3 Rfid)

Rfid Label (51662 1595 3 Rfid)
Close-up of a label on a package for Ampicillin 250 mg injection powder for solution by HF Acquisition Co LLC, DBA HealthFirst. The label includes a barcode, various numeric codes including the NDC, and the instruction to see the manufacturer's insert for details. The label specifies distribution by HF Acquisitions Co LLC in Mukilteo, WA.*
FDA Label Image

Pouch Labeling (51662 1595 2 Pouch Labeling Sept 2022)

Pouch Labeling (51662 1595 2 Pouch Labeling Sept 2022)
Label text for AMPICILLIN injection, USP 250 mg per 10 mL vial showing NDC 51662-1595-2, lot number, and expiration date. Instructions for use include mixing with 1 mL diluent, dosage guidelines for children and adults, storage conditions, and a note that vial stoppers do not contain natural rubber latex. Manufacturer is HF Acquisition Co LLC in Mukilteo, WA.*
FDA Label Image

Vial Label (Vial Sept 2022)

Vial Label (Vial Sept 2022)
Label for AMPICILLIN injection, powder for solution, 250 mg per vial. The label indicates ampicillin sodium equivalent to 250 mg, for intravenous or intramuscular use. Manufacturer is HF Acquisition Co LLC, DBA HealthFirst. The label includes NDC 65219-014-01 and various usage instructions and warnings.*
FDA Label Image

Case Labeling (51662 1595 3 Case Labeling Sept 2022)

Case Labeling (51662 1595 3 Case Labeling Sept 2022)
Packaging label for AMPICILLIN injection powder for solution, USP 250 mg per 10 mL vial. The label indicates a case containing 10 vials. It includes lot number, expiration date, usage instructions for intramuscular and intravenous injection, and manufacturer information as HF Acquisition Co LLC, Mukilteo, WA. The label also notes that vial stoppers do not contain natural rubber latex.*
FDA Label Image

Serialized Rfid Labeling (51662 1595 3 Serialized Rfid Label Sept 2022)

Serialized Rfid Labeling (51662 1595 3 Serialized Rfid Label Sept 2022)
Packaging label for AMPICILLIN 250 mg injection powder for solution. Label includes barcodes and numeric codes, with instructions to see the manufacturer's package insert and mentions HF Acquisition Co LLC, DBA HealthFirst, located in Mukilteo, WA.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.